Perioperative considerations for neoadjuvant immunotherapy in non–small cell lung cancer
Brendon M. Stiles, Boris Sepesi, Stephen Broderick, Matthew J. Bott
Topics & Concepts
MedicineLung cancerOncologyDurvalumabInternal medicineClinical trialImmunotherapyAtezolizumabCancerStage (stratigraphy)PerioperativeSurgeryPembrolizumabPaleontologyBiologyCancer Immunotherapy and BiomarkersLung Cancer Treatments and MutationsColorectal and Anal Carcinomas